Chidamide enhances the sensitivity of gastric cancer to 5-fluorouracil chemotherapy by suppressing the HDAC3/HNF4A/TYMS axis
Abstract Gastric cancer (GC) is among the most common malignant tumors in China and leads in incidence across all cancer types. For over three decades, the standard treatment has been traditional chemotherapy, which often involves monotherapy with 5-fluorouracil (5-FU) or its combination with other...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group
2025-12-01
|
| Col·lecció: | Cell Death and Disease |
| Accés en línia: | https://doi.org/10.1038/s41419-025-08247-y |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|